BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu H, Lu HY. Nonalcoholic fatty liver disease and cardiovascular disease. World J Gastroenterol 2014; 20(26): 8407-8415 [PMID: 25024598 DOI: 10.3748/wjg.v20.i26.8407]
URL: https://www.wjgnet.com/1948-5182/full/v20/i26/8407.htm
Number Citing Articles
1
Rajkumar Chinnadurai, James Ritchie, Darren Green, Philip A Kalra. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney diseaseNephrology Dialysis Transplantation 2019; 34(3): 449 doi: 10.1093/ndt/gfx381
2
Rongjiong Zheng, Zhennan Du, Mingming Wang, Yushan Mao, Wenjie Mao. A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver diseaseLipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0913-3
3
Qun Liu, Shou-Sheng Liu, Zhen-Zhen Zhao, Ben-Tian Zhao, Shui-Xian Du, Wen-Wen Jin, Yong-Ning Xin. TRIB1 rs17321515 gene polymorphism increases the risk of coronary heart disease in general population and non-alcoholic fatty liver disease patients in Chinese Han populationLipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1108-2
4
Yu Mi Kang, Chang Hee Jung, Yun Kyung Cho, Seung Eun Lee, Min Jung Lee, Jenie Yoonoo Hwang, Eun Hee Kim, Joong-Yeol Park, Woo Je Lee, Hong-Kyu Kim, Petter Bjornstad. Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese populationPLOS ONE 2017; 12(4): e0175762 doi: 10.1371/journal.pone.0175762
5
Toufik Mahfood Haddad, Shadi Hamdeh, Arun Kanmanthareddy, Venkata M. Alla. Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysisDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2017; 11: S209 doi: 10.1016/j.dsx.2016.12.033
6
Aki Juhani Käräjämäki, Risto Bloigu, Heikki Kauma, Y. Antero Kesäniemi, Olli-Pekka Koivurova, Juha Perkiömäki, Heikki Huikuri, Olavi Ukkola. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomesMetabolism 2017; 66: 55 doi: 10.1016/j.metabol.2016.06.009
7
Christopher L. Wray. Advances in the Anesthetic Management of Solid Organ TransplantationAdvances in Anesthesia 2017; 35(1): 95 doi: 10.1016/j.aan.2017.07.005
8
Gaofeng Yuan, Mengmeng Xu, Meijuan Tan, Jian Dong, Xiaoe Chen. Supplementation with Docosahexaenoic Acid and Vitamin E Improves Hepatic Triglyceride Accumulation Induced by High‐Fat Diet in MiceEuropean Journal of Lipid Science and Technology 2021; 123(1): 2000224 doi: 10.1002/ejlt.202000224
9
Benedicto Crespo-Facorro, Jose Maria Pelayo-Teran, Jacqueline Mayoral-van Son. Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive ReviewNeurology and Therapy 2016; 5(2): 105 doi: 10.1007/s40120-016-0050-8
10
Hui-Li Tan, Kok-Gan Chan, Priyia Pusparajah, Acharaporn Duangjai, Surasak Saokaew, Tahir Mehmood Khan, Learn-Han Lee, Bey-Hing Goh. Rhizoma Coptidis: A Potential Cardiovascular Protective AgentFrontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00362
11
Nasrin Sharifi, Reza Amani, Eskandar Hajiani, Bahman Cheraghian. Women may respond different from men to vitamin D supplementation regarding cardiometabolic biomarkersExperimental Biology and Medicine 2016; 241(8): 830 doi: 10.1177/1535370216629009
12
Xiao-Yan Wang, Xue-Lan Song, Yi Zhang, Gan Luo, Hai-Chuan Tai, Zhao-Heng Lin, Pei-Li Zhu, Nan Sun, Zhu-Sheng Chu, Zhi-Ling Yu, Si-Yuan Pan, Jin-Fa Tang, Kam-Ming Ko, Jenny Wilkinson. Evaluation of Beneficial and Adverse Effects of a Diet Supplemented with Schisandrae Fructus Seed Ethanol Extract on Lipid and Glucose Metabolism in Normal and Hypercholesterolemic/Hyperglycemic MiceEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/8858962
13
Ivana Mikolasevic, Sandra Milic, Tamara Turk Wensveen, Ivana Grgic, Ivan Jakopcic, Davor Stimac, Felix Wensveen, Lidija Orlic. Nonalcoholic fatty liver disease - A multisystem disease?World Journal of Gastroenterology 2016; 22(43): 9488-9505 doi: 10.3748/wjg.v22.i43.9488
14
Veeravich Jaruvongvanich, Kamonkiat Wirunsawanya, Anawin Sanguankeo, Sikarin Upala. Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysisDigestive and Liver Disease 2016; 48(12): 1410 doi: 10.1016/j.dld.2016.09.002
15
Lu Liu, Yong Yu, Meng Zhao, Dongmei Zheng, Xu Zhang, Qingbo Guan, Chao Xu, Ling Gao, Jiajun Zhao, Haiqing Zhang. Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism PatientsInternational Journal of Endocrinology 2017; 2017: 1 doi: 10.1155/2017/5753039
16
Dawn M. Torres, Stephen A. Harrison. Alcoholic and Non-Alcoholic Fatty Liver Disease2016; : 183 doi: 10.1007/978-3-319-20538-0_9
17
Vasilios G Athyros, Konstantinos Tziomalos, Niki Katsiki, Michael Doumas, Asterios Karagiannis, Dimitri P Mikhailidis. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An updateWorld Journal of Gastroenterology 2015; 21(22): 6820-6834 doi: 10.3748/wjg.v21.i22.6820
18
Sarita Singhal, Susan S. Baker, Robert D. Baker, Lixin Zhu. The Liver2018; : 15 doi: 10.1016/B978-0-12-803951-9.00002-1
19
Radojica V. Stolic, Goran Z. Trajkovic, Mirjana M. Kostic, Sasa R. Sovtic, Andrijana M. Odalovic, Biljana D. Krdzic, Maja V. Sipic, Snezana Lazic, Zorica N. Sojevic-Timotijevic. Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patientsInternational Urology and Nephrology 2016; 48(6): 883 doi: 10.1007/s11255-016-1237-8
20
Narjes Khavasi, Mohammadhossein Somi, Ebrahim Khadem, Mohammad Hossein Ayati, Mohamadali Torbati, Seyyed Muhammad Bagher Fazljou. Daily Consumption of the Capparis spinosa Reduces Some Atherogenic Indices in Patients with Non-alcoholic Fatty Liver Disease: A Randomized, Double-blind, Clinical TrialIranian Red Crescent Medical Journal 2018; (In Press) doi: 10.5812/ircmj.63446
21
Naoko Nakanishi, Yoshitaka Hashimoto, Takuro Okamura, Akihiro Ohbora, Takao Kojima, Masahide Hamaguchi, Michiaki Fukui. A weight regain of 1.5 kg or more and lack of exercise are associated with nonalcoholic fatty liver disease recurrence in menScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-99036-y
22
Alen Lovric, Marit Granér, Elias Bjornson, Muhammad Arif, Rui Benfeitas, Kristofer Nyman, Marcus Ståhlman, Markku O. Pentikäinen, Jesper Lundbom, Antti Hakkarainen, Reijo Sirén, Markku S. Nieminen, Nina Lundbom, Kirsi Lauerma, Marja-Riitta Taskinen, Adil Mardinoglu, Jan Boren. Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolomeScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-31865-w
23
Mark CC Cheah, Arthur J McCullough, George Boon-Bee Goh. Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver DiseaseJournal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00009
24
Alessandro Ciavarella, Davide Gnocchi, Carlo Custodero, Gennaro Mariano Lenato, Giorgio Fiore, Carlo Sabbà, Antonio Mazzocca. Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver diseaseThrombosis Research 2021; 198: 139 doi: 10.1016/j.thromres.2020.12.002
25
Gerardo Rodriguez-Araujo, Andrew J. Krentz. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease2019; : 275 doi: 10.1007/978-3-030-11748-1_11
26
Carla Sá, Ana Rita Oliveira, Cátia Machado, Marisa Azevedo, Cristina Pereira-Wilson. Effects on Liver Lipid Metabolism of the Naturally Occurring Dietary Flavone Luteolin-7-glucosideEvidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/647832
27
Abdulrahman Ismaiel, Dan L. Dumitraşcu. Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis—Literature ReviewFrontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00202
28
Stefania Kiapidou, Christina Liava, Maria Kalogirou, Evangelos Akriviadis, Emmanouil Sinakos. Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?Annals of Hepatology 2020; 19(2): 134 doi: 10.1016/j.aohep.2019.07.013
29
Yaohui Wang, Yuhua Zeng, Changwei Lin, Zhiheng Chen. Hypertension and non-alcoholic fatty liver disease proven by transient elastographyHepatology Research 2016; 46(13): 1304 doi: 10.1111/hepr.12688
30
Elisabete Martins, Ana Oliveira. NAFLD and cardiovascular diseasePorto Biomedical Journal 2018; 3(2): e2 doi: 10.1016/j.pbj.0000000000000002
31
Masayoshi Takeuchi, Jun-ichi Takino, Akiko Sakasai-Sakai, Takanobu Takata, Tadashi Ueda, Mikihiro Tsutsumi, Hideyuki Hyogo, Sho-ichi Yamagishi. Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategiesWorld Journal of Hepatology 2014; 6(12): 880-893 doi: 10.4254/wjh.v6.i12.880
32
Tessa Brand, Inge Christina Lamberta van den Munckhof, Marinette van der Graaf, Kiki Schraa, Helena Maria Dekker, Leonardus Antonius Bernardus Joosten, Mihai Gheorghe Netea, Niels Peter Riksen, Jacqueline de Graaf, Joseph Henricus Wilhelmus Rutten. Superficial vs Deep Subcutaneous Adipose Tissue: Sex-Specific Associations With Hepatic Steatosis and Metabolic TraitsThe Journal of Clinical Endocrinology & Metabolism 2021; 106(10): e3881 doi: 10.1210/clinem/dgab426
33
Fatemeh Sadeghi, Sasan Amanat, Mohammad Bakhtiari, Hadis Asadimehr, Mohammad Ali Okhovat, Masood Hosseinzadeh, Seyed Mohammad Mazloomi, Maryam Gholamalizadeh, Saeid Doaei. The effects of high fructose fruits and honey on the serum level of metabolic factors and nonalcoholic fatty liver diseaseJournal of Diabetes & Metabolic Disorders 2021;  doi: 10.1007/s40200-021-00916-x
34
Karthik Chandrasekharan, William Alazawi. Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?Frontiers in Pharmacology 2020; 10 doi: 10.3389/fphar.2019.01413
35
O. Ya. Babak, A. D. Bashkirova . Parameters of Carbohydrate Metabolism and Expression of Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease and Hypertensive Depending on Lipid ParametersUkraïnsʹkij žurnal medicini, bìologìï ta sportu 2019; 4(4): 64 doi: 10.26693/jmbs04.04.064
36
Shenyi Yin, Yu Fan, Hanshuo Zhang, Zhihua Zhao, Yang Hao, Juan Li, Changhong Sun, Junyu Yang, Zhenjun Yang, Xiao Yang, Jian Lu, Jianzhong Jeff Xi. Differential TGFβ pathway targeting by miR-122 in humans and mice affects liver cancer metastasisNature Communications 2016; 7(1) doi: 10.1038/ncomms11012
37
Hamza El Hadi, Angelo Di Vincenzo, Roberto Vettor, Marco Rossato. Relationship between Heart Disease and Liver Disease: A Two-Way StreetCells 2020; 9(3): 567 doi: 10.3390/cells9030567
38
Ruby Kumari, Prof. Santosh Kumar, Debarshi Jana. DYSLIPIDEMIA IN NON ALCOHOLIC FATTY LIVER DISEASEINTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 2021; : 24 doi: 10.36106/ijsr/9739450
39
Asako Nogami, Masato Yoneda, Takashi Kobayashi, Takaomi Kessoku, Yasushi Honda, Yuji Ogawa, Kaori Suzuki, Wataru Tomeno, Kento Imajo, Hiroyuki Kirikoshi, Tomoko Koide, Hirotoshi Fujikawa, Satoru Saito, Atsushi Nakajima. Assessment of 10‐year changes in liver stiffness using vibration‐controlled transient elastography in non‐alcoholic fatty liver diseaseHepatology Research 2019; 49(8): 872 doi: 10.1111/hepr.13349
40
Jihyun Kim, Da Young Lee, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee, Susanne Kaser. Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammationPLOS ONE 2017; 12(7): e0180118 doi: 10.1371/journal.pone.0180118
41
Seyedeh Neda Mousavi, Amirhosein Faghihi, Majid Motaghinejad, Maryam Shiasi, Fatemeh Imanparast, Hamid Lorvand Amiri, Farzad Shidfar. Zinc and Selenium Co-supplementation Reduces Some Lipid Peroxidation and Angiogenesis Markers in a Rat Model of NAFLD-Fed High Fat DietBiological Trace Element Research 2018; 181(2): 288 doi: 10.1007/s12011-017-1059-2
42
Alessandra Gentili, Giulia Daviddi, Stefano De Vuono, Maria Anastasia Ricci, Francesco Di Filippo, Abdalkader Alaeddin, Massimo R. Mannarino, Marcello Boni, Gaetano Vaudo, Graziana Lupattelli. Non-alcoholic fatty liver disease fibrosis score and preclinical vascular damage in morbidly obese patientsDigestive and Liver Disease 2016; 48(8): 904 doi: 10.1016/j.dld.2016.04.004
43
Mostafa Fazeli, Mohammad Mohammad-Zadeh, Zahra Meshkat, Hamideh Ghazizadeh, Elham Barati, Gordon A Ferns, Majid Ghayour-Mobarhan. Metabolic Syndrome in Children and Adolescents: Looking to New MarkersCurrent Treatment Options in Pediatrics 2021; 7(3): 152 doi: 10.1007/s40746-021-00226-7
44
Jung Eun Lee, Yong Jae Lee, Soo Yoon Chung, Hee Woo Cho, Byoung Jin Park, Dong Hyuk Jung, Kottarappat N Dileepan. Severity of nonalcoholic fatty liver disease is associated with subclinical cerebro-cardiovascular atherosclerosis risk in Korean menPLOS ONE 2018; 13(3): e0193191 doi: 10.1371/journal.pone.0193191
45
Aki J. Käräjämäki, Olli-Pekka Pätsi, Markku Savolainen, Y. Antero Kesäniemi, Heikki Huikuri, Olavi Ukkola, Giovanni Targher. Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study)PLOS ONE 2015; 10(11): e0142937 doi: 10.1371/journal.pone.0142937
46
Jelena Stevanović, Jorge Beleza, Pedro Coxito, António Ascensão, José Magalhães. Physical exercise and liver “fitness”: Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver diseaseMolecular Metabolism 2020; 32: 1 doi: 10.1016/j.molmet.2019.11.015
47
María José Morlán-Coarasa, María Teresa Arias-Loste, Víctor Ortiz-García de la Foz, Obdulia Martínez-García, Carmen Alonso-Martín, Javier Crespo, Manuel Romero-Gómez, Emilio Fábrega, Benedicto Crespo-Facorro. Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional studyPsychopharmacology 2016; 233(23-24): 3947 doi: 10.1007/s00213-016-4422-7
48
Dan-Qin Sun, Wen-Yue Liu, Sheng-Jie Wu, Gui-Qi Zhu, Martin Braddock, Dong-Chu Zhang, Ke-Qing Shi, Dan Song, Ming-Hua Zheng. Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver diseaseOncotarget 2016; 7(5): 5728 doi: 10.18632/oncotarget.6799
49
Kun Lian, Yu‐Nan Feng, Rong Li, Hao‐Lin Liu, Peng Han, Lei Zhou, Cheng‐Xiang Li, Qin Wang. Middle‐ and high‐molecular weight adiponectin levels in relation to nonalcoholic fatty liver diseaseJournal of Clinical Laboratory Analysis 2020; 34(4) doi: 10.1002/jcla.23148
50
Sabine Hörist-Kollmann, Jeanette Strametz-Juranek. Female Dietary Patterns and the Pathogenesis of NAFLDGender and the Genome 2018; 2(2): 49 doi: 10.1177/2470289718787091
51
L. Farzin, S. Asghari, M. Rafraf, M. Asghari-Jafarabadi, M. Shirmohammadi. No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver diseaseInternational Journal for Vitamin and Nutrition Research 2020; 90(3-4): 279 doi: 10.1024/0300-9831/a000528
52
Aleksandra Klisic, Nebojsa Kavaric, Ana Ninic. Predictive values of serum uric acid and Alanine-aminotransferase for fatty liver index in Montenegrin populationJournal of Medical Biochemistry 2019; 38(4): 407 doi: 10.2478/jomb-2019-0001
53
Heidi Storgaard, Lise L. Gluud, Cathy Bennett, Magnus F. Grøndahl, Mikkel B. Christensen, Filip K. Knop, Tina Vilsbøll, Noel Christopher Barengo. Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-AnalysisPLOS ONE 2016; 11(11): e0166125 doi: 10.1371/journal.pone.0166125
54
Rina Wu, Feng Hou, Xiaomin Wang, Yong Zhou, Kai Sun, Youxin Wang, Henghui Liu, Jing Wu, Ruiping Zhao, Jiang Hu. Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification in a Northern Chinese Population: a Cross Sectional StudyScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09851-5
55
Saumya Jayakumar, Stephen A. Harrison, Rohit Loomba. Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver DiseaseCurrent Hepatology Reports 2016; 15(2): 86 doi: 10.1007/s11901-016-0296-8